UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

Journal of lipid research, 2007-04, Vol.48 (4), p.751-762

2007

Volltextzugriff (PDF)

The Disease Activity Score and the EULAR Response Criteria

Rheumatic diseases clinics of North America, 2009-11, Vol.35 (4), p.745-757

2009

Volltextzugriff (PDF)

Exercise participation has increased in patients with Rheumatoid Arthritis: A cross-sectional comparison between two Dutch RA cohorts

Mediterranean journal of rheumatology, 2018-12, Vol.29 (4), p.199-206

2018

Volltextzugriff (PDF)

Burden of disease in treated rheumatoid arthritis patients: Going beyond the joint

Seminars in arthritis and rheumatism, 2014-02, Vol.43 (4), p.479-488

2014

Volltextzugriff (PDF)

Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs

Journal of rheumatology, 2009-10, Vol.36 (10), p.2164-2170

2009

Volltextzugriff (PDF)

Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization

Rheumatology advances in practice, 2021-01, Vol.5 (1), p.rkaa079-rkaa079

2021

Volltextzugriff (PDF)

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals

Mediators of Inflammation, 2012-01, Vol.2012 (2012), p.1-9

2012

Volltextzugriff (PDF)

Patient Self-Management and Tracking

Rheumatic diseases clinics of North America, 2019-05, Vol.45 (2), p.187-195

2019

Volltextzugriff (PDF)

A different perspective: Inflammatory rheumatic diseases and other organs

Best practice & research. Clinical rheumatology, 2016-10, Vol.30 (5), p.787-788

2016

Volltextzugriff (PDF)

Tailored Therapist-guided Internet-based Cognitive-behavioural Treatment for Psoriasis and Rheumatoid Arthritis: Two Case Reports

Acta dermato-venereologica, 2018-02, Vol.98 (2), p.225-233

2018

Volltextzugriff (PDF)

Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis

Journal of rheumatology, 2009-04, Vol.36 (4), p.724-730

2009

Volltextzugriff (PDF)

Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial

Pain (Amsterdam), 2002-11, Vol.100 (1), p.141-153

2002

Volltextzugriff (PDF)

One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology

Rheumatology advances in practice, 2020-01, Vol.4 (2), p.rkaa042-rkaa042

2020

Volltextzugriff (PDF)

Personalizing treatment targets in rheumatoid arthritis by using a simple prediction model

Journal of rheumatology, 2015-03, Vol.42 (3), p.398-404

2015

Volltextzugriff (PDF)

The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis

Clinical and experimental rheumatology, 2016-09, Vol.34 (5 Suppl 101), p.S40

2016

Volltextzugriff (PDF)

The reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritis

Journal of rheumatology, 2009-10, Vol.36 (10), p.2171-2177

2009

Volltextzugriff (PDF)

The detection of monosodium urate crystals in synovial fluid after long-term and varying storage conditions

Joint, bone, spine : revue du rhumatisme, 2015-12, Vol.82 (6), p.470-471

2015

Volltextzugriff (PDF)

Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment

BMC rheumatology, 2019-01, Vol.3 (1), p.3-3, Article 22

2019

Volltextzugriff (PDF)

The Use of Captopril in Rheumatoid Arthritis: Combining Treatment Targets

Canadian journal of cardiology, 2013-05, Vol.29 (5), p.639.e13-639.e13

2013

Volltextzugriff (PDF)

Risk factors for longer term psychological distress in well-functioning fibromyalgia patients: A prospective study into prognostic factors

Patient education and counseling, 2010-07, Vol.80 (1), p.126-129

2010

Volltextzugriff (PDF)

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

Annals of the rheumatic diseases, 2018-01, Vol.77 (1), p.48-54

2018

Volltextzugriff (PDF)

Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study

Annals of the rheumatic diseases, 2017-10, Vol.76 (10), p.1693-1699

2017

Volltextzugriff (PDF)

The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients

Annals of the rheumatic diseases, 2015-06, Vol.74 (6), p.998-1003

2015

Volltextzugriff (PDF)

Genetics of rheumatoid arthritis contributes to biology and drug discovery

Nature (London), 2014-02, Vol.506 (7488), p.376-381

2014

Volltextzugriff (PDF)

1 – 25 von 253

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(218)
Mit Volltextzugriff
(190)

Publikationsform

Artikel
(252)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(227)
Humans
(220)
Life Sciences & Biomedicine
(219)
Rheumatology
(186)
Female
(148)
Male
(146)
Middle Aged
(134)
Rheumatoid Arthritis
(132)
Aged
(104)
Arthritis, Rheumatoid - Drug Therapy
(98)
Adult
(96)
Biological And Medical Sciences
(89)
Medical Sciences
(86)
Antirheumatic Agents - Therapeutic Use
(71)
Severity Of Illness Index
(68)
Diseases Of The Osteoarticular System
(67)
Inflammatory Joint Diseases
(62)
Treatment Outcome
(57)
Cohort Studies
(40)
Tumor Necrosis Factor-Alpha - Antagonists & Inhibitors
(37)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of TNF-α in chronic inflammatory conditions, intermediary metabolism, and cardiovascular risk

The Disease Activity Score and the EULAR Response Criteria

Exercise participation has increased in patients with Rheumatoid Arthritis: A cross-sectional comparison between two Dutch RA cohorts

Burden of disease in treated rheumatoid arthritis patients: Going beyond the joint

Adherence rates and associations with nonadherence in patients with rheumatoid arthritis using disease modifying antirheumatic drugs

Telemedicine in the management of rheumatoid arthritis: maintaining disease control with less health-care utilization

Atherogenic Index and High-Density Lipoprotein Cholesterol as Cardiovascular Risk Determinants in Rheumatoid Arthritis: The Impact of Therapy with Biologicals

Patient Self-Management and Tracking

A different perspective: Inflammatory rheumatic diseases and other organs

Tailored Therapist-guided Internet-based Cognitive-behavioural Treatment for Psoriasis and Rheumatoid Arthritis: Two Case Reports

Circulating leptin and adiponectin concentrations during tumor necrosis factor blockade in patients with active rheumatoid arthritis

Tailored cognitive-behavioral therapy in early rheumatoid arthritis for patients at risk: a randomized controlled trial

One-year results after transitioning from etanercept originator to biosimilar in a setting promoting shared decision-making in rheumatology

Personalizing treatment targets in rheumatoid arthritis by using a simple prediction model

The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis

The reason for discontinuation of the first tumor necrosis factor (TNF) blocking agent does not influence the effect of a second TNF blocking agent in patients with rheumatoid arthritis

The detection of monosodium urate crystals in synovial fluid after long-term and varying storage conditions

Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment

The Use of Captopril in Rheumatoid Arthritis: Combining Treatment Targets

Risk factors for longer term psychological distress in well-functioning fibromyalgia patients: A prospective study into prognostic factors

Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study

The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients

Genetics of rheumatoid arthritis contributes to biology and drug discovery

Suchergebnisse filtern